El interés en corto de Datasea da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Datasea. Los datos de interés en corto se actualizan cada dos semanas.

Datasea (NASDAQ:DTSS) Bolsa, Informe de interés en corto

Datasea

Datasea Inc is a technology company. Its offers provides acoustic business services (focusing on high-tech acoustic technologies and applications such as ultrasound, infrasound, and Schumann resonance), 5G application services (5G AI multimodal digital business), and other products and services to various corporate and individual customers. The business activity of the group functions through China.

Datasea Inc

ETFs with <a href="https://www.benzinga.com/etfs">significant exposure to Chinese stocks</a> surged on Monday, as stronger-than-expected manufacturing data and expectations of fresh stimulus from Beijing boosted investor confidence. The gains helped recoup some of last week's losses, which were driven by economic uncertainty and trade tensions between <a href="https://www.benzinga.com/markets/25/02/43938959/trump-targets-chinas-tech-sector-with-stricter-biden-era-chip-curbs-it-will-backfire-says-beijing">China and the U.S</a>. 
Several ETFs tracking Chinese stocks inched up in response to the market rebound.
ETFs To Watch
KraneShares CSI China Internet ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KWEB#NYSE">KWEB</a>) Gained 0.6% at 12:51 pm EST as Chinese tech stocks rebounded amid optimism about a consumer demand recovery. Alibaba Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) is one of the fund&#8217;s top holdings.
GraniteShares 2x Long BABA Daily ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BABX#NASDAQ">BABX</a>): Mirrored Alibaba's rebound as investors anticipated stimulus-driven consumer spending growth and gained 2.3% as of 12:51 pm EST.
SPDR S&amp;P China ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GXC#NYSE">GXC</a>): Gained as investor sentiment improved toward high-growth technology stocks listed on China's Star Market. Alibaba holds one of the premium positions in the fund&#8217;s holdings.
Also Read: <a href="https://www.benzinga.com/25/02/44040003/alibaba-expands-ai-workforce-while-deepseek-slashes-model-prices-in-market-battle">Alibaba Expands AI Intern Workforce While DeepSeek Slashes Model Prices in Market Battle</a>
Market Rebound Amid Trade War Concerns
Hong Kong's benchmark Hang Seng Index rose 1.2% by lunch break, recovering from Friday's biggest decline in four months, while the Hang Seng Tech Index gained 0.7%. On the mainland, the blue chip CSI300 Index added 0.5%, and the Shanghai Composite Index climbed 0.3%, reversing some of Friday's 2% drop.
The rebound came after both official and private-sector surveys showed China's <a href="https://www.cnbc.com/2025/03/03/china-february-caixin-pmi.html">manufacturing </a>activity expanded at the fastest pace in three months in February. Higher purchase volumes and rising new orders contributed to stronger industrial production, easing investor concerns about the country's economic strength.
Despite the moderate gains, market sentiment remained cautious as both China and the U.S. prepared to impose additional tariffs on each other. President Donald Trump announced an additional 10% tariff on all Chinese imports. In response, China is expected to implement countermeasures, likely targeting American agricultural exports, according to reports from Global Times.
However, analysts at Bank of America noted that these moves are likely negotiation tactics rather than signals of an impending full-scale trade war. &#8220;We think these moves are still tactics to put more bargaining chips on the table before negotiations take place,&#8221; they wrote in a research note.
Stimulus Expectations
Investors are now closely watching the &#8220;Two Sessions&#8221; meetings set to begin on Tuesday, where Beijing is expected to announce fresh economic stimulus measures. Policymakers are likely to maintain China's economic growth <a href="https://www.bloomberg.com/news/articles/2025-03-02/xi-prepares-to-unveil-china-stimulus-plan-as-trade-war-heats-up?sref=TBDibEcD">target </a>at around 5% while outlining a budget deficit of 4% of GDP, according to Bloomberg.
Despite cautious investor expectations regarding the parliamentary meetings, Goldman Sachs analysts highlighted that policy support aimed at boosting domestic demand could lead to further stock market gains. Historically, stimulus measures have disproportionately benefited high-quality, discounted Chinese stocks, making ETFs a preferred vehicle for capitalizing on market shifts.
Alibaba And Blue-Chip Stocks In Focus
Alibaba Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) remains a key focus for investors as it represents both China's growing technology sector and consumer spending trends. As economic stimulus measures trickle down, Alibaba and similar blue-chip stocks are poised to be among the first to attract fresh capital. 
Also, last week, Alibaba made its video and image-generating AI model, Wan 2.1, <a href="https://www.benzinga.com/25/02/43970279/alibaba-and-deepseek-intensify-ai-showdown-challenging-openai-and-nvidias-market-dominance">publicly available on ModelScope and HuggingFace</a> for academic, research, and commercial use. It has committed $53 billion over three years to enhance its AI and cloud infrastructure. Additionally, Alibaba CEO Eddie Wu met Chongqing's party secretary to discuss potential AI collaborations. These developments have sent Alibaba on a rally.
Investors eager to capitalize on the market&#8217;s resurgence may find opportunities in ETFs that provide broad exposure to China's leading companies. However, trade tensions and policy announcements in the coming weeks will likely determine the sustainability of this rebound.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/03/44085268/market-mayhem-5-etfs-that-soared-amid-volatility-last-week">Market Mayhem: 5 ETFs That Soared Amid Volatility Last Week</a></li>
</ul>
Photo: Shutterstock

Emerging Market ETFs

ETFs

BABA

BABX

KSTR

KWEB

YINN

3 China-Focused ETFs To Watch As Stronger Manufacturing Data, Stimulus Hopes Boost Sentiment

Deep-pocketed investors have adopted a bullish approach towards Chevron (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CVX usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 16 extraordinary options activities for Chevron. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 50% leaning bullish and 43% bearish. Among these notable options, 5 are puts, totaling $307,850, and 11 are calls, amounting to $2,773,712.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $100.0 to $170.0 for Chevron over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Chevron stands at 2878.79, with a total volume reaching 12,242.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Chevron, situated within the strike price corridor from $100.0 to $170.0, throughout the last 30 days.
<h3>Chevron 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741029356_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$2.12</td>
<td>$2.01</td>
<td>$2.02</td>
<td>$170.00</td>
<td>$2.0M</td>
<td>1.1K</td>
<td>10.0K</td>
</tr>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$15.55</td>
<td>$15.25</td>
<td>$15.25</td>
<td>$150.00</td>
<td>$228.7K</td>
<td>1.2K</td>
<td>216</td>
</tr>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$9.9</td>
<td>$9.85</td>
<td>$9.85</td>
<td>$165.00</td>
<td>$172.3K</td>
<td>1.8K</td>
<td>236</td>
</tr>
<tr>
<td>CVX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$4.1</td>
<td>$3.9</td>
<td>$4.05</td>
<td>$155.00</td>
<td>$124.7K</td>
<td>915</td>
<td>398</td>
</tr>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$61.05</td>
<td>$59.5</td>
<td>$59.66</td>
<td>$100.00</td>
<td>$71.5K</td>
<td>133</td>
<td>12</td>
</tr>
</tbody>
</table>

<h3>About Chevron</h3>
Chevron is an integrated energy company with exploration, production, and refining operations worldwide. It is the second-largest oil company in the United States with production of 3.1 million of barrels of oil equivalent a day, including 7.7 million cubic feet a day of natural gas and 1.8 million of barrels of liquids a day. Production activities take place in North America, South America, Europe, Africa, Asia, and Australia. Its refineries are in the US and Asia for total refining capacity of 1.8 million barrels of oil a day. Proven reserves at year-end 2023 stood at 11.1 billion barrels of oil equivalent, including 6.0 billion barrels of liquids and 30.4 trillion cubic feet of natural gas.
Following our analysis of the options activities associated with Chevron, we pivot to a closer look at the company's own performance.
<h3>Chevron's Current Market Status</h3>
<ul>
<li>Trading volume stands at 4,164,384, with CVX's price down by -2.84%, positioned at $154.12.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 53 days.</li>
</ul>
<h3>What Analysts Are Saying About Chevron</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $176.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Chevron, which currently sits at a price target of $184. 
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Buy rating on Chevron with a target price of $194. 
&#x2A; Consistent in their evaluation, an analyst from Truist Securities keeps a Hold rating on Chevron with a target price of $160. 
&#x2A; An analyst from Barclays has decided to maintain their Overweight rating on Chevron, which currently sits at a price target of $171. 
&#x2A; In a cautious move, an analyst from RBC Capital downgraded its rating to Outperform, setting a price target of $175. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Chevron options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Options

Markets

Smart Money Is Betting Big In CVX Options

Financial giants have made a conspicuous bullish move on Astera Labs. Our analysis of options history for Astera Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) revealed 13 unusual trades.
Delving into the details, we found 53% of traders were bullish, while 38% showed bearish tendencies. Out of all the trades we spotted, 9 were puts, with a value of $1,585,931, and 4 were calls, valued at $214,495.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $55.0 to $140.0 for Astera Labs over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Astera Labs's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Astera Labs's significant trades, within a strike price range of $55.0 to $140.0, over the past month.
<h3>Astera Labs Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741029351_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ALAB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$10.4</td>
<td>$9.9</td>
<td>$10.0</td>
<td>$55.00</td>
<td>$500.0K</td>
<td>39</td>
<td>1.0K</td>
</tr>
<tr>
<td>ALAB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$10.0</td>
<td>$9.9</td>
<td>$10.0</td>
<td>$55.00</td>
<td>$391.0K</td>
<td>39</td>
<td>391</td>
</tr>
<tr>
<td>ALAB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/07/25</td>
<td>$2.85</td>
<td>$1.9</td>
<td>$2.65</td>
<td>$67.00</td>
<td>$157.0K</td>
<td>74</td>
<td>9</td>
</tr>
<tr>
<td>ALAB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$15.8</td>
<td>$15.5</td>
<td>$15.75</td>
<td>$65.00</td>
<td>$149.6K</td>
<td>5.5K</td>
<td>95</td>
</tr>
<tr>
<td>ALAB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$16.0</td>
<td>$15.9</td>
<td>$16.0</td>
<td>$75.00</td>
<td>$139.2K</td>
<td>276</td>
<td>87</td>
</tr>
</tbody>
</table>

<h3>About Astera Labs</h3>
Astera Labs Inc designs and delivers semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform integrates semiconductor technology, microcontrollers, sensors, and software to enhance performance, scalability, and data management. The company offers products such as integrated circuits (ICs), boards, and modules, catering to hyperscalers and system OEMs. The company's solutions focus on data, network, and memory management in AI-driven platforms.
In light of the recent options history for Astera Labs, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Astera Labs's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 4,320,063, the ALAB's price is down by -6.25%, now at $69.7. </li>
<li>RSI readings suggest the stock is currently may be oversold.</li>
<li>Anticipated earnings release is in 82 days.</li>
</ul>
<h3>What Analysts Are Saying About Astera Labs</h3>
In the last month, 2 experts released ratings on this stock with an average target price of $132.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Needham lowers its rating to Buy with a new price target of $140. 
&#x2A; An analyst from Craig-Hallum persists with their Buy rating on Astera Labs, maintaining a target price of $125. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Astera Labs, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

ALAB

Astera Labs's Options Frenzy: What You Need to Know

Investors with a lot of money to spend have taken a bullish stance on SolarEdge Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with SEDG, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 10 uncommon options trades for SolarEdge Technologies.
This isn't normal.
The overall sentiment of these big-money traders is split between 50% bullish and 40%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $110,620, and 7 are calls, for a total amount of $1,276,821.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $2.5 to $80.0 for SolarEdge Technologies over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for SolarEdge Technologies options trades today is 649.0 with a total volume of 3,594.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for SolarEdge Technologies's big money trades within a strike price range of $2.5 to $80.0 over the last 30 days.
<h3>SolarEdge Technologies Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741029346_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SEDG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$13.1</td>
<td>$12.95</td>
<td>$12.95</td>
<td>$2.50</td>
<td>$259.0K</td>
<td>1.8K</td>
<td align="right">985</td>
</tr>
<tr>
<td>SEDG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$12.95</td>
<td>$12.9</td>
<td>$12.95</td>
<td>$2.50</td>
<td>$259.0K</td>
<td>1.8K</td>
<td align="right">785</td>
</tr>
<tr>
<td>SEDG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$13.0</td>
<td>$12.95</td>
<td>$12.95</td>
<td>$2.50</td>
<td>$259.0K</td>
<td>1.8K</td>
<td align="right">585</td>
</tr>
<tr>
<td>SEDG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$13.0</td>
<td>$12.95</td>
<td>$13.0</td>
<td>$2.50</td>
<td>$176.3K</td>
<td>1.8K</td>
<td align="right">236</td>
</tr>
<tr>
<td>SEDG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$13.1</td>
<td>$12.95</td>
<td>$13.0</td>
<td>$2.50</td>
<td>$130.0K</td>
<td>1.8K</td>
<td align="right">100</td>
</tr>
</tbody>
</table>

<h3>About SolarEdge Technologies</h3>
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers.
Following our analysis of the options activities associated with SolarEdge Technologies, we pivot to a closer look at the company's own performance.
<h3>SolarEdge Technologies's Current Market Status</h3>
<ul>
<li>Trading volume stands at 2,867,751, with SEDG's price down by -3.34%, positioned at $15.94.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 65 days.</li>
</ul>
<h3>What Analysts Are Saying About SolarEdge Technologies</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $18.6.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Goldman Sachs has decided to maintain their Buy rating on SolarEdge Technologies, which currently sits at a price target of $31. 
&#x2A; An analyst from Jefferies has decided to maintain their Underperform rating on SolarEdge Technologies, which currently sits at a price target of $12. 
&#x2A; Consistent in their evaluation, an analyst from Piper Sandler keeps a Underweight rating on SolarEdge Technologies with a target price of $10. 
&#x2A; In a positive move, an analyst from Morgan Stanley has upgraded their rating to Equal-Weight and adjusted the price target to $18. 
&#x2A; An analyst from UBS persists with their Neutral rating on SolarEdge Technologies, maintaining a target price of $22. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for SolarEdge Technologies, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

SEDG

Spotlight on SolarEdge Technologies: Analyzing the Surge in Options Activity

Retailer Target Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) could highlight strong Black Friday sales and the impact tariffs could have on consumers when the company reports fourth-quarter financials before <a href="https://www.benzinga.com/earnings">market open Tuesday.</a>
Here are the analyst estimates and commentary, plus key items to watch ahead of the report.
Earnings Estimates: Analysts expect Target to report fourth-quarter revenue of $30.84 billion. That&#8217;s down from $31.92 billion in last year's fourth quarter, according to data<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent030325&amp;t=be2bearmibe3na1"> from Benzinga Pro.</a>
The company has missed analyst estimates for revenue in two straight quarters. It beat estimates in six of the last 10 quarters overall.
Analysts expect Target to report fourth-quarter earnings per share of $2.26, down from $2.98 in last year's fourth quarter. The company missed analyst estimates for earnings per share in one straight quarter while beating estimates in six of the last 10 quarters.
Target's <a href="https://www.benzinga.com/news/earnings/24/11/42085436/target-q3-earnings-supply-chain-chaos-hits-bottomline-slashes-annual-profit-outlook-stock-tanks">guidance for the fourth quarter</a> calls for earnings per share to be in a range of $1.85 to $2.45.
Read Also: <a href="https://www.benzinga.com/news/earnings/25/02/44041104/how-to-earn-500-a-month-from-target-stock-ahead-of-q4-earnings">How To Earn $500 A Month From Target Stock Ahead Of Q4 Earnings</a>
What Analysts Are Saying: Target previously reported holiday sales growth of +2.8%, but maintained its earnings per share range, which could suggest a heavier impact from promotions and discounts, Truist analyst Scot Ciccarelli said in a new investor note.
The analyst has a Hold rating and $134 price target. Target's first quarter also appears to be off to a slow start, the analyst added.
"We also think there is a chance that the company could pursue significant price investments (which we believe is needed) to improve their competitive pricing and drive longer-term share gains," Ciccarelli said.
The analyst said holiday sales growth was in-line with investor expectations and that is the assumption for the fourth quarter.
"Based on 2 years of sluggish sales performance and what appears to be a soft start to 1Q25, we think the company will likely guide comps towards a 0% to +2% range."
Ciccarelli said competitive pressure from Amazon.com and Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) "continue to mount" for Target.
"We remain cautious on TGT given continued share pressures and think that the company may need to accelerate their pricing investments to improve its competitive positioning."
Goldman Sachs analyst Kate McShane maintained a Buy rating and raised the price target on Target stock from $164 to $166<a href="https://www.benzinga.com/25/01/43102000/target-the-bull-vs-bear-case-for-2025"> in January.</a>
The analyst said Target underperformed other retailers in 2024, but the company's higher mix of discretionary products could help in the future.
"We also think TGT can benefit over time from leveraging its strong fulfillment model and its alternative revenue streams, including Roundel (advertising), Target Circle (membership), and Target Plus (marketplace)," McShane said.
The analyst said Target stock had "limited downside potential" at the time.
Here are other recent<a href="https://www.benzinga.com/quote/TGT/analyst-ratings"> analyst ratings on Target </a>and their price targets:
<ul>
<li>JPMorgan: Maintained Neutral rating, raised price target from $139 to $146</li>
<li>Bernstein: Maintained Market Perform rating, raised price target from $139 to $142</li>
<li>Guggenheim: Maintained Buy rating, raised price target from $145 to $155</li>
</ul>
Key Items to Watch: A recent <a href="https://www.placer.ai/blog/visitation-trends-and-shopping-behaviors-at-walmart-target">report </a>from Placer.ai showed that Target store visits were up 1.0% in November, down 1.3% in December and up 3.6% in January, which could signal improved sales for the first quarter.
The same report recently showed Walmart's foot traffic patterns matching up closely with the company's comparable sales growth for its<a href="https://www.benzinga.com/news/earnings/25/02/43846469/walmart-q4-earnings-shine-but-soft-fy26-outlook-disappoints-street"> recently reported quarter.</a>
While Walmart is a rival, data from Placer.ai shows that Target has customers with higher median household income, has a larger share of repeat monthly visitors and a higher market share of shopping from households with children.
The quarterly results and comparison to recent results from Walmart, who beat analyst estimates for revenue and earnings per share, could show if higher-income shoppers are struggling more or less than lower-income shoppers.
Target's fourth-quarter results will include Black Friday and holiday shopping sales. The company's partnership with Taylor Swift on an<a href="https://www.benzinga.com/general/entertainment/24/12/42351922/trump-predicted-taylor-swift-sales-would-drop-target-data-shows-over-800k-sold"> exclusive Eras Tour book </a>saw lines outside stores and strong sales over the Black Friday shopping holiday.
In the third quarter, Target highlighted Beauty, Food &amp; Beverage and Essentials as sectors seeing strong year-over-year growth.
Investors and analysts will be looking for commentary on what sectors are seeing strong sales and how the future impact of tariffs on certain goods could impact the retail giant.
Price Action: Target stock is up 0.3% to $124.56 on Monday versus a 52-week trading range of $120.21 to $181.86. Target stock is down 9.2% year-to-date in 2025 and down 17.2% over the past year.
Compare that to Walmart stock, which trades at $98.11 versus a 52-week trading range of $58.40 to $105.30. Walmart stock is up 9.0% year-to-date in 2025 and up 65.4% over the past year.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/retail-sales/25/02/43977330/target-and-champion-launch-exclusive-activewear-line">Target And Champion Launch Exclusive Activewear Line</a></li>
</ul>
Image: Shutterstock

Analyst Color

Price Target

Previews

Reiteration

Analyst Ratings

Trading Ideas

Target Q4 Earnings Preview: Why One Analyst Remains 'Cautious' On Retailer After Walmart's Report

News

Contracts

Politics

General

TSLA

Democratic Senator Blumenthal Asks State Department To Answer Questions On Reported Plan To Purchase Tesla Cybertrucks

WIIM

AMRC

Ameresco shares are trading lower. The company announced the acquisition of ASA Controls.

CNH Industrial shares are trading lower after Baird downgraded the stock from Outperform to Neutral and cut its price target from $16 to $15.

On Monday, AbbVie&nbsp;Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) and Gubra A/S announced a license agreement to develop GUB014295, a long-acting amylin analog for obesity. GUB014295 is currently in a <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/n44069717/abbvie-and-gubra-announce-license-agreement-to-develop-an-amylin-analog-for-the-treatment-of-obesi" rel="noreferrer noopener">Phase 1 clinical trial</a>.
&#8220;Our partnership with Gubra marks our entry into the obesity field, offering a compelling opportunity based on the potential to address patient needs while also fostering long-term growth for our company,&#8221; said&nbsp;Robert Michael, CEO of AbbVie.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/01/43403416/is-big-pharma-about-to-win-goldman-sachs-weighs-in-on-340b-and-medicaid-shifts" rel="noreferrer noopener">Is Big Pharma About To Win? Goldman Sachs Weighs In On 340B And Medicaid Shifts</a>
A potential long-acting amylin analog, GUB014295 is an agonist that specifically activates amylin and calcitonin receptors.
Amylin, a satiety hormone, has been identified as a potential therapeutic target for obesity, given its role in activating signals to the brain that result in appetite suppression and the reduction of food intake while also acting as an inhibitory signal to delay gastric emptying.&nbsp;
Under the terms of the agreement, AbbVie will lead the development and commercialization activities of GUB014295 globally.
Gubra will receive&nbsp;$350 million&nbsp;in total upfront payment and be eligible to receive up to&nbsp;$1.875 billion&nbsp;in development, commercial and sales milestone payments with tiered royalties on global net sales.
William Blair analyst Matt Phipps writes, &#8220;We believe this transaction highlights a growing interest in amylin agonists (and particularly dual amylin/calcitonin receptor agonists, or DACRAs) as a next wave of obesity assets, particularly for companies looking to break into the field despite being well behind GLP-1 leaders Eli Lilly And Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) and Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>).&#8221;
The analyst highlights a key question is whether AbbVie will develop GUB014295 as a standalone treatment, offering a milder weight loss option for those who cannot tolerate or do not respond to GLP-1/GIP agonists.
Alternatively, the company may combine it with GLP-1/GIP drugs like Novo Nordisk's CagriSema for greater weight loss. Investors are also interested in whether AbbVie plans to expand further in the obesity market through new business deals.
Price Action: ABBV stock is up 0.84% at $210.78 at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44080418/trimble-and-stmicroelectronics-launch-precision-positioning-tech-for-iot-applications" target="_blank" rel="noreferrer noopener">Trimble, STMicroelectronics Launch Precision Positioning Tech For IoT Applications</a></li>
</ul>
Photo via Shutterstock.

Biotech

Large Cap

Health Care

ABBV

GUBRF

AbbVie Becomes Another Big Pharma To Enter Obesity Treatment Race

<a href="https://www.bloomberg.com/news/articles/2025-03-03/saudi-s-pif-to-anchor-new-gulf-focused-goldman-sachs-funds" title="https://www.bloomberg.com/news/articles/2025-03-03/saudi-s-pif-to-anchor-new-gulf-focused-goldman-sachs-funds">https://www.bloomberg.com/news/articles/2025-03-03/saudi-s-pif-to-anchor-new-gulf-focused-goldman-sachs-funds</a>

Global

'Saudi's PIF To Anchor New Gulf-Focused Goldman Sachs Funds; GSAM Funds To Target Private Credit, Public Equity In Region; Wall Street Titans Increasingly Expand Presence In Middle East' - Bloomberg News

NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) stock is trading lower on Monday. Reportedly, Chinese buyers are acquiring the company&#8217;s <a href="https://www.benzinga.com//node/44079411">artificial intelligence (AI) chips</a> despite U.S. export regulations.
What To Know: According to <a href="https://www.wsj.com/tech/china-nvidia-blackwell-chips-ai-531fed0c">The Wall Street Journal</a>, buyers are bypassing restrictions by routing orders for computing systems with restricted technology through companies registered in neighboring countries such as Malaysia, Vietnam and Taiwan. These entities then resell the technology to buyers in China.
Authorities in these nearby regions have started implementing measures to make such attempts more difficult to carry out.
The U.S. government began implementing controls on chip sales to China in 2022 under now former President Joe Biden. Biden signed multiple orders aiming to prevent China from acquiring certain chips. How President Donald Trump and his administration will respond remains unknown.
Two Chinese universities have reportedly obtained AI servers containing restricted technology, while a separate merchant is suspected of possessing servers with controlled components. In response, Nvidia has tightened its &#8220;know-your-customer&#8221; policies and increased site inspections to ensure compliance with export rules. 
The company also claims that anonymous traders cannot provide the services and support that customers seeking advanced AI technology want.
See Also: <a href="https://www.benzinga.com/25/03/44084261/philip-morris-considers-selling-us-cigar-business-as-it-pushes-towards-smoke-free-products-bloomberg">Philip Morris Considers Selling US Cigar Business As It Pushes Towards Smoke-Free Products: Bloomberg</a>
NVDA Price Action: At the time of writing, Nvidia shares are trading 6.3% lower at $116.99, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: via Shutterstock

Movers

NVDA

What's Going On With NVIDIA Shares Monday?

As previously disclosed, on December&nbsp;22, 2023, Scilex Holding Company (the "Company") entered into a Sales Agreement (the "Sales Agreement") with B. Riley Securities Inc., Cantor Fitzgerald&nbsp;&amp; Co. and H.C. Wainwright&nbsp;&amp; Co., LLC (the "Sales Agents"), pursuant to which the Company may offer and sell shares of its common stock from time to time through the Sales Agents, acting as the sales agents.
On February&nbsp;28, 2025, the Company voluntarily terminated the Sales Agreement, effective as of March&nbsp;5, 2025. During the term of the Sales Agreement, the Company sold an aggregate of 2,764,187 shares of its common stock for aggregate gross proceeds to the Company of approximately $2,693,840. The Sales Agreement was terminable at will by the Company with no penalty.

SCLX

Scilex Ends Sales Agreement With B. Riley, Cantor Fitzgerald, H.C. Wainwright With No Penalty; During The Term Of The Agreement Sold 2.76M Shares For $2.69M

EOG Resources shares are trading lower. Morgan Stanley cut its price target on the stock from $143 to $142.

Biglari Holdings shares are trading lower after the company reported a year-over-year decrease in FY24 results.

Throughout the last three months, 5 analysts have evaluated CubeSmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CUBE#NYSE">CUBE</a>), offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $46.8, a high estimate of $50.00, and a low estimate of $44.00. This current average represents a 7.51% decrease from the previous average price target of $50.60. 
<img src="https://www.benzinga.com/files/images/story/2025/1741028486_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The analysis of recent analyst actions sheds light on the perception of CubeSmart by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brad Heffern</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$48.00</td>
<td>$53.00</td>
</tr>
<tr>
<td>Eric Luebchow</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$44.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Ki Bin Kim</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$47.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Brendan Lynch</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$50.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Omotayo Okusanya</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Hold</td>
<td>$45.00</td>
<td>$46.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to CubeSmart. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of CubeSmart compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for CubeSmart's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into CubeSmart's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CUBE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on CubeSmart analyst ratings.</a>
<h2>Unveiling the Story Behind CubeSmart</h2>
CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Most of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. The company derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.
<h3>Unraveling the Financial Story of CubeSmart</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: CubeSmart displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 0.98%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Real Estate sector.
Net Margin: CubeSmart's net margin is impressive, surpassing industry averages. With a net margin of 38.06%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): CubeSmart's ROE excels beyond industry benchmarks, reaching 3.6%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): CubeSmart's ROA excels beyond industry benchmarks, reaching 1.62%. This signifies efficient management of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.06.
<h2>What Are Analyst Ratings?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CUBE

Analyst Expectations For CubeSmart's Future

Analysts' ratings for ProPetro Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PUMP#NYSE">PUMP</a>) over the last quarter vary from bullish to bearish, as provided by 4 analysts.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $10.75, a high estimate of $12.00, and a low estimate of $10.00. This upward trend is evident, with the current average reflecting a 4.07% increase from the previous average price target of $10.33.
<img src="https://www.benzinga.com/files/images/story/2025/1741028475_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive ProPetro Holding. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Anderson</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$11.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Stephen Gengaro</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$12.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Scott Gruber</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$10.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Arun Jayaram</td>
<td>JP Morgan</td>
<td>Announces</td>
<td>Neutral</td>
<td>$10.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to ProPetro Holding. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of ProPetro Holding compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of ProPetro Holding's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of ProPetro Holding's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/PUMP/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on ProPetro Holding analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>All You Need to Know About ProPetro Holding</h2>
ProPetro Holding Corp is a Texas-based oilfield services company. It provides hydraulic fracturing, wireline, and other complementary services to oil and gas companies engaged in the exploration and production of North American oil and natural gas resources. The company focused on the Permian Basin. The operating segments of the company are hydraulic fracturing which generates key revenue, wireline, cementing, and power generation service.
<h3>A Deep Dive into ProPetro Holding's Financials</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Challenges: ProPetro Holding's revenue growth over 3 months faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately -7.83%. This indicates a decrease in top-line earnings. When compared to others in the Energy sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: ProPetro Holding's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -5.32%, the company may face hurdles in effective cost management.
Return on Equity (ROE): ProPetro Holding's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -2.07%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): ProPetro Holding's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -1.36%, the company may face hurdles in achieving optimal financial returns.
Debt Management: ProPetro Holding's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.21.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PUMP

Assessing ProPetro Holding: Insights From 4 Financial Analysts

Investors with a lot of money to spend have taken a bearish stance on AST SpaceMobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ASTS, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 48 uncommon options trades for AST SpaceMobile.
This isn't normal.
The overall sentiment of these big-money traders is split between 31% bullish and 54%, bearish.
Out of all of the special options we uncovered, 6 are puts, for a total amount of $285,270, and 42 are calls, for a total amount of $2,360,560.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $20.0 to $45.0 for AST SpaceMobile during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for AST SpaceMobile options trades today is 3093.04 with a total volume of 43,877.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for AST SpaceMobile's big money trades within a strike price range of $20.0 to $45.0 over the last 30 days.
<h3>AST SpaceMobile Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741028468_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ASTS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/07/25</td>
<td>$8.15</td>
<td>$8.0</td>
<td>$8.07</td>
<td>$21.00</td>
<td>$188.1K</td>
<td>448</td>
<td>1.6K</td>
</tr>
<tr>
<td>ASTS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$11.85</td>
<td>$11.2</td>
<td>$11.4</td>
<td>$30.00</td>
<td>$100.3K</td>
<td>1.3K</td>
<td>88</td>
</tr>
<tr>
<td>ASTS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$10.0</td>
<td>$9.8</td>
<td>$10.0</td>
<td>$45.00</td>
<td>$100.0K</td>
<td>9.3K</td>
<td>117</td>
</tr>
<tr>
<td>ASTS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$10.5</td>
<td>$9.9</td>
<td>$10.0</td>
<td>$45.00</td>
<td>$99.0K</td>
<td>9.3K</td>
<td>217</td>
</tr>
<tr>
<td>ASTS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$9.95</td>
<td>$9.75</td>
<td>$9.75</td>
<td>$20.00</td>
<td>$97.5K</td>
<td>1.1K</td>
<td>203</td>
</tr>
</tbody>
</table>

<h3>About AST SpaceMobile</h3>
AST SpaceMobile Inc is a satellite designer and manufacturer. The company is building a cellular broadband network in space to operate directly with standard, unmodified mobile devices, and off-the-shelf mobile phones based on extensive IP and patent portfolio. It has focused on eliminating the connectivity gaps faced by mobile subscribers and finally bringing broadband to the billions who remain unconnected. The Company's spaceMobile Service is being designed to provide cost-effective, high-speed Cellular Broadband services to end-users who are out of terrestrial cellular coverage using existing mobile devices.
In light of the recent options history for AST SpaceMobile, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of AST SpaceMobile</h3>
<ul>
<li>With a volume of 8,687,168, the price of ASTS is down -2.56% at $26.41. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 0 days.</li>
</ul>
<h3>What Analysts Are Saying About AST SpaceMobile</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $30.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $30. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest AST SpaceMobile options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

ASTS

Looking At AST SpaceMobile's Recent Unusual Options Activity

Myriad Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYGN#NASDAQ">MYGN</a>) has been analyzed by 10 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Myriad Genetics and provided 12-month price targets. The average target is $17.9, accompanied by a high estimate of $29.00 and a low estimate of $11.00. Observing a downward trend, the current average is 18.64% lower than the prior average price target of $22.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1741028464_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The perception of Myriad Genetics by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Derik De Bruin</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$11.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Andrew Cooper</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$19.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Lu Li</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$16.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>John Wilkin</td>
<td>Craig-Hallum</td>
<td>Announces</td>
<td>Buy</td>
<td>$29.00</td>
<td>-</td>
</tr>
<tr>
<td>John Peterson</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$14.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Matthew Sykes</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Buy</td>
<td>$18.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Mason Carrico</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$20.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Derik De Bruin</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$13.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Lu Li</td>
<td>UBS</td>
<td>Announces</td>
<td>Neutral</td>
<td>$18.00</td>
<td>-</td>
</tr>
<tr>
<td>Puneet Souda</td>
<td>Leerink Partners</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$21.00</td>
<td>$30.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Myriad Genetics. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Myriad Genetics compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Myriad Genetics's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Myriad Genetics's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/MYGN/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Myriad Genetics analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Discovering Myriad Genetics: A Closer Look</h2>
Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.
<h3>Myriad Genetics: Delving into Financials</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Decline in Revenue: Over the 3 months period, Myriad Genetics faced challenges, resulting in a decline of approximately -1.27% in revenue growth as of 31 December, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Myriad Genetics's net margin excels beyond industry benchmarks, reaching -20.18%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Myriad Genetics's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -5.93% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Myriad Genetics's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of -4.03%, the company showcases efficient use of assets and strong financial health.
Debt Management: Myriad Genetics's debt-to-equity ratio surpasses industry norms, standing at 0.2. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>The Basics of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MYGN

Analyst Expectations For Myriad Genetics's Future

Eaton Corp shares are trading lower after Barclays cut its price target on the stock from $353 to $325.

Financial giants have made a conspicuous bullish move on Intuit. Our analysis of options history for Intuit (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) revealed 12 unusual trades.
Delving into the details, we found 50% of traders were bullish, while 8% showed bearish tendencies. Out of all the trades we spotted, 8 were puts, with a value of $668,247, and 4 were calls, valued at $213,250.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $500.0 to $700.0 for Intuit during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Intuit's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Intuit's whale activity within a strike price range from $500.0 to $700.0 in the last 30 days. 
<h3>Intuit 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741028461_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>INTU</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$25.9</td>
<td>$25.8</td>
<td>$25.8</td>
<td>$590.00</td>
<td>$286.3K</td>
<td align="right">93</td>
<td align="right">114</td>
</tr>
<tr>
<td>INTU</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$42.1</td>
<td>$40.5</td>
<td>$42.0</td>
<td>$570.00</td>
<td>$155.6K</td>
<td align="right">96</td>
<td align="right">43</td>
</tr>
<tr>
<td>INTU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/07/25</td>
<td>$10.6</td>
<td>$9.3</td>
<td>$9.95</td>
<td>$610.00</td>
<td>$99.1K</td>
<td align="right">227</td>
<td align="right">113</td>
</tr>
<tr>
<td>INTU</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$27.1</td>
<td>$25.2</td>
<td>$26.2</td>
<td>$520.00</td>
<td>$65.5K</td>
<td align="right">35</td>
<td align="right">25</td>
</tr>
<tr>
<td>INTU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$42.6</td>
<td>$41.9</td>
<td>$42.6</td>
<td>$650.00</td>
<td>$46.8K</td>
<td align="right">107</td>
<td align="right">11</td>
</tr>
</tbody>
</table>

<h3>About Intuit</h3>
Intuit serves small and midsize businesses with accounting software QuickBooks and online marketing platform Mailchimp. The company also operates retail tax filing tool TurboTax, personal finance platform Credit Karma, and a suite of professional tax offerings for accountants. Founded in the mid-1980s, Intuit enjoys a dominant market share for small business accounting and do-it-yourself tax filing in the US.
In light of the recent options history for Intuit, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Current Position of Intuit</h3>
<ul>
<li>Trading volume stands at 688,041, with INTU's price down by -0.92%, positioned at $608.17.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 80 days.</li>
</ul>
<h3>What The Experts Say On Intuit</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $718.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Citigroup continues to hold a Buy rating for Intuit, targeting a price of $726. 
&#x2A; An analyst from Scotiabank persists with their Sector Perform rating on Intuit, maintaining a target price of $600. 
&#x2A; Consistent in their evaluation, an analyst from BMO Capital keeps a Outperform rating on Intuit with a target price of $714. 
&#x2A; In a cautious move, an analyst from Piper Sandler downgraded its rating to Overweight, setting a price target of $785. 
&#x2A; Consistent in their evaluation, an analyst from Mizuho keeps a Outperform rating on Intuit with a target price of $765. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Intuit, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

INTU

Intuit Unusual Options Activity For March 03

Earnings

Small Cap

Press Releases

Datasea Pre-announces Estimated First Quarter 2025 Fiscal Year Revenue of approximately $22.7 Million, Up 230% Year-Over-Year

Offerings

Datasea Announces the Closing of a $4.0 Million Private Offering, Primarily Funded by the Company's CEO and Director

Datasea Reports First Quarter 2025 Revenue of $21 Million, Up 206% Year-over-Year

Datasea Pre-Announces Full-Year Fiscal 2025 Revenue of $90 Million, Representing a Year-Over-Year Increase of 275%, with Expected Significant Gross Profit Improvement

Datasea Hosts Product Promotion Event and Signs Sales Agreement for up to 300,000 High-Tech Acoustic Units

Datasea Announces Entry into Agreements that Will Place its Acoustic High-Tech Products in a Total of 263 Beauty Stores in Northern China

Datasea Announces Continued Expansion with Agreements to Place its Acoustic High-Tech Products in an Additional 200 Beauty Stores in Northern China

Datasea Pre-Announces Second Quarter Revenue of $20.5 Million, up 81% Year-over-Year

Datasea Reports Second Fiscal Quarter 2025 Revenue of $20.5 Million, Up 81.4% Year-over-Year

Promising New Investments and Joint Venture Agreements for Wedding Photography and Light Show Projects in China: Golden Heaven Group Holdings (Nasdaq: GDHG)

Comments

Datasea

Interés en corto

Datasea (NASDAQ:DTSS) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL